Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of infertility across population base
3.2.1.2 Demographical shift towards acceptance of assisted reproductive technology (ART)
3.2.1.3 Technological advancements in assisted reproductive technology
3.2.1.4 Rising awareness regarding assisted reproductive technology
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of procedures
3.2.2.2 Social barriers and lack of advanced infrastructure in emerging countries
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Pricing analysis, 2021 - 2032
3.6.1 Procedure pricing analysis, by region
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Product
5.2.1 Media
5.2.2 Catheters
5.2.3 Needles
5.2.4 Vitrification devices
5.2.5 Incubators
5.2.6 Other products
5.3 Procedure
5.3.1 By type
5.3.1.1 Fresh donor
5.3.1.2 Fresh nondonor
5.3.1.3 Frozen donor
5.3.1.4 Frozen nondonor
5.3.2 By technology
5.3.2.1 In-vitro fertilization (IVF)
5.3.2.1.1 IVF with intracytoplasmic sperm injection (ICSI)
5.3.2.1.2 IVF without ICSI
5.3.2.2 Artificial insemination - intrauterine insemination (AI-IUI)
Chapter 6 Market Estimates and Forecast, By End-User/Provider, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Hospitals
6.3 Fertility clinics
6.4 Other end-users/providers
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Egypt
7.6.3 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Esco Micro Pte. Ltd
8.2 Gynotec
8.3 Hamilton Thorne Ltd.
8.4 Indira IVF Hospital Private Limited
8.5 Ivy Fertility
8.6 Kitazato Corporation
8.7 Laboratoire CCD
8.8 Liverpool Partners Group
8.9 Merck KGaA
8.10 MISTRAL FERTILITY CLINICS S.L.
8.11 NidaCon International AB
8.12 Sumitomo Mitsui Financial Group, Inc.
8.13 The Cooper Companies, Inc.
8.14 Thermo Fisher Scientific Inc.
8.15 Vitrolife Group
8.16 Western Fertility Institute
